Confidently Navigating ADPKD: Understanding the New KDIGO Guidelines

Led by two PKD Foundation Centers of Excellence clinic directors, this session will focus on treatment options, lifestyle modifications, and mental well-being. There will be plenty of time to ask your questions and get expert answers. Whether you have ADPKD, have family with ADPKD, or you’re a healthcare provider, everyone is encouraged to attend.

You’ll Learn:

Learn about tolvaptan and other treatment options
Discover lifestyle and dietary changes that support kidney health
Explore strategies for pain management and mental well-being
Understand the importance of a multidisciplinary care team

Guest Speakers:

Fouad Chebib, M.D., FASN, is a nephrologist, associate professor of medicine, and PKD Foundation Center of Excellence (COE) clinic director at Mayo Clinic Jacksonville. In addition to leading Mayo Clinic Jacksonville’s Discovery and Translational PKD Research Laboratory, he pioneered the first FDA-approved tolvaptan clinic (at Mayo Clinic) and spearheads clinical trials translating novel ADPKD treatments into practice. He’s a leading researcher and educator, having authored over 85 peer-reviewed publications and developed comprehensive educational resources on PKD. He serves on the Board of Directors of the PKD Foundation and is dedicated to eliminating the need for dialysis in ADPKD patients.

Pranav Garimella, MBBS, MPH, FASN, is the PKD Foundation COE advisory committee co-chair and director of the PKD Foundation COE at UC San Diego. As a board-certified nephrologist, his expertise is chronic kidney disease, polycystic kidney disease, kidney stones, and metabolic bone disease. Dr. Garimella is also a trained epidemiologist and active researcher, focusing on kidney function biomarkers, cardiovascular disease risk, and peripheral artery disease in kidney patients while also serving as an associate editor for BMC Nephrology.